Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Breast Cancer Research and Treatment|January 1, 1982
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancerJ C Allegra, T M Woodcock, S P Richman, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|March 31, 2004
Thioether side chain cyclization for helical peptide formation: inhibitors of estrogen receptor-coactivator interactionsA K Galande, K S Bramlett, T P Burris, et al.Archives of Surgery (Chicago, Ill. : 1960)|June 1, 1993
Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic diseaseS Galandiuk, S Miseljic, A R Yang, et al.Clinical Chemistry|August 1, 1981
14C-labeled proteins as markers for gradient analysis of steroid-hormone receptorsD J Ledden, R C Feldhoff, P W Feldhoff, et al.The Journal of Surgical Research|June 1, 1987
The effects of ischemia on estrogen and progesterone receptor profiles in the rodent uterusK I Bland, B E Freedman, P L Harris, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancerC. Tecimer, D. L. Doering, L. J. Goldsmith, et al.Gynecologic Oncology|January 4, 2001
Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancerC Tecimer, D L Doering, L J Goldsmith, et al.Journal of the National Cancer Institute|February 24, 2001
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodesB Fisher, J Dignam, E Tan-Chiu, et al.Cancer|February 15, 1996
Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteriJ S Sanfilippo, S Miseljic, A R Yang, et al.International Journal of Cancer|December 15, 1980
Comparison of steroid receptor levels in renal-cell carcinoma and autologous normal kidneyG P Hemstreet, J L Wittliff, A M Sarrif, et al.Pageof 10